These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
103 related articles for article (PubMed ID: 239234)
21. Studies on the antibacterial activity of 1-substituted 1,4-dihydro-7-(2-(5-nitro-2-furyl)vinyl)-4-oxo-1,8-naphthyridine derivatives. Nagasaki S; Nakazawa N; Osada Y; Hashizume T; Oshima Y Chem Pharm Bull (Tokyo); 1972 Apr; 20(4):639-49. PubMed ID: 5045609 [No Abstract] [Full Text] [Related]
22. 3-Trifluoromethylquinoxaline N,N'-dioxides as anti-trypanosomatid agents. Identification of optimal anti-T. cruzi agents and mechanism of action studies. Benitez D; Cabrera M; Hernández P; Boiani L; Lavaggi ML; Di Maio R; Yaluff G; Serna E; Torres S; Ferreira ME; Vera de Bilbao N; Torres E; Pérez-Silanes S; Solano B; Moreno E; Aldana I; López de Ceráin A; Cerecetto H; González M; Monge A J Med Chem; 2011 May; 54(10):3624-36. PubMed ID: 21506600 [TBL] [Abstract][Full Text] [Related]
23. Pyridoquinoxaline N-oxides. 1. A new class of antitrichomonal agents. Glazer EA; Chappel LR J Med Chem; 1982 Jul; 25(7):766-9. PubMed ID: 7108893 [TBL] [Abstract][Full Text] [Related]
26. Quinoxaline N,N'-dioxide derivatives and related compounds as growth inhibitors of Trypanosoma cruzi. Structure-activity relationships. Aguirre G; Cerecetto H; Di Maio R; González M; Alfaro ME; Jaso A; Zarranz B; Ortega MA; Aldana I; Monge-Vega A Bioorg Med Chem Lett; 2004 Jul; 14(14):3835-9. PubMed ID: 15203172 [TBL] [Abstract][Full Text] [Related]
27. Piromidic acid, a new antibacterial agent: antibacterial properties. Shimizu M; Nakamura S; Takase Y Antimicrob Agents Chemother (Bethesda); 1970; 10():117-22. PubMed ID: 4939730 [No Abstract] [Full Text] [Related]
28. In vivo antibacterial activity of diaveridine-sulfonamide combinations. Carroll PT; Robb CA; Tippett LO; Langston JB Invest Urol; 1971 Jul; 9(1):21-4. PubMed ID: 4935215 [No Abstract] [Full Text] [Related]
29. Chloramphenicol for oral treatment of canine urinary tract infections. Ling GV; Ruby AL J Am Vet Med Assoc; 1978 Apr; 172(8):914-6. PubMed ID: 348660 [TBL] [Abstract][Full Text] [Related]
30. Synthesis of new quinoxaline-2-carboxylate 1,4-dioxide derivatives as anti-Mycobacterium tuberculosis agents. Jaso A; Zarranz B; Aldana I; Monge A J Med Chem; 2005 Mar; 48(6):2019-25. PubMed ID: 15771444 [TBL] [Abstract][Full Text] [Related]
31. Studies on furan derivatives. X. Preparation of 2-substituted 3-(5-nitro-2-furyl)guinoxaline 1,4-dioxides and determination of their antibacterial activity. Tanaka A; Usui T Chem Pharm Bull (Tokyo); 1981 Jan; 29(1):110-5. PubMed ID: 7261188 [No Abstract] [Full Text] [Related]
32. [Antibiotic activity in vivo of a staphylococcin produced by a strain of Micrococcus sp]. Gabbrielli G; Lo Bianco A; Farina W Boll Soc Ital Biol Sper; 1968 Nov; 44(22):1890-4. PubMed ID: 4899171 [No Abstract] [Full Text] [Related]
33. [Chemotherapeutic study of ampicillin in experimental infections]. Petrova MA; Berezina EK; Chavdarova VB Antibiotiki; 1968 Sep; 13(9):815-20. PubMed ID: 4884475 [No Abstract] [Full Text] [Related]
39. [Epidemiology of the urinary tract infection in patients with prolonged catheterization in an intensive care unit]. Kolb R; Rotter M Anaesthesist; 1973 May; 22(5):239-42. PubMed ID: 4198502 [No Abstract] [Full Text] [Related]